Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction-Reference-Cited by-同舟云学术

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction

Published:2016-10 Issue:4 Volume:20 Page:429-442
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Foster Toshana L.,Wilson Harry,Iyer Shilpa S.,Coss Karen,Doores Katie,Smith Sarah,Kellam Paul,Finzi Andrés,Borrow Persephone,Hahn Beatrice H.,Neil Stuart J.D.

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference46 articles.

1. Development of the antibody response in acute HIV-1 infection;Aasa-Chapman;AIDS,2004

2. Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection;Aasa-Chapman;J. Virol.,2005

3. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection;Abel;J. Virol.,2005

4. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry;Amini-Bavil-Olyaee;Cell Host Microbe,2013

5. Interferon-induced transmembrane protein 3 is a type II transmembrane protein;Bailey;J. Biol. Chem.,2013

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies;Nature Communications;2024-08-26

2. Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection;Frontiers in Immunology;2024-08-16

3. Help or Hinder: Protein Host Factors That Impact HIV-1 Replication;Viruses;2024-08-10

4. Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics—Learning from the Past and Present to Prepare for the Future;Pathogens;2024-08-10

5. The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies;Viruses;2024-05-06